{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:52:56Z","timestamp":1787874776396,"version":"build-2784847793"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10096-024-04840-9","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T07:03:00Z","timestamp":1714201380000},"page":"1453-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evolution, control and success of combination therapy with Ampicilin-sulbactam\/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit"],"prefix":"10.1007","volume":"43","author":[{"given":"Emmanuel","family":"Dudoignon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Cam\u00e9l\u00e9na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Deniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mait\u00e9","family":"Chaussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Coutrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Guillemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Cupaciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Pharaboz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Chaouat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Merim\u00e8che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Plaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Ber\u00e7ot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"D\u00e9pret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"4840_CR1","doi-asserted-by":"publisher","first-page":"115564","DOI":"10.1016\/j.biopha.2023.115564","volume":"167","author":"J Teng","year":"2023","unstructured":"Teng J, Imani S, Zhou A, Zhao Y, Du L, Deng S et al (2023) Combatting resistance: understanding multi-drug resistant pathogens in intensive care units. Biomed Pharmacother Biomedecine Pharmacother 167:115564. https:\/\/doi.org\/10.1016\/j.biopha.2023.115564","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"4840_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijid.2018.11.371","volume":"79","author":"AL Munier","year":"2019","unstructured":"Munier AL, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay JL et al (2019) Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. Int J Infect Dis IJID off Publ Int Soc Infect Dis 79:179\u2013184. https:\/\/doi.org\/10.1016\/j.ijid.2018.11.371","journal-title":"Int J Infect Dis IJID off Publ Int Soc Infect Dis"},{"key":"4840_CR3","doi-asserted-by":"publisher","first-page":"tkaa033","DOI":"10.1093\/burnst\/tkaa033","volume":"8","author":"S Corcione","year":"2020","unstructured":"Corcione S, Lupia T, De Rosa FG, Host and Microbiota Interaction Study Group (ESGHAMI) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2020) Microbiome in the setting of burn patients: implications for infections and clinical outcomes. Burns Trauma 8:tkaa033. https:\/\/doi.org\/10.1093\/burnst\/tkaa033","journal-title":"Burns Trauma"},{"issue":"6","key":"4840_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/jac\/dkab015","volume":"76","author":"KA Parsels","year":"2021","unstructured":"Parsels KA, Mastro KA, Steele JM, Thomas SJ, Kufel WD (2021) Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections. J Antimicrob Chemother 76(6):1379\u20131391. https:\/\/doi.org\/10.1093\/jac\/dkab015","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"4840_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","volume":"21","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R et al (2021) Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis 21(2):226\u2013240. https:\/\/doi.org\/10.1016\/S1473-3099(20)30796-9","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4840_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10156-012-0404-9","volume":"18","author":"G Mellon","year":"2012","unstructured":"Mellon G, Clec\u2019h C, Picard B, Cohen Y, Jaur\u00e9guy F (2012) Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin\/sulbactam combined with rifampicin and fosfomycin. J Infect Chemother 18(6):958\u2013960. https:\/\/doi.org\/10.1007\/s10156-012-0404-9","journal-title":"J Infect Chemother"},{"issue":"5","key":"4840_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/antibiotics10050577","volume":"10","author":"F Pasteran","year":"2021","unstructured":"Pasteran F, Cedano J, Baez M, Albornoz E, Rapoport M, Osteria J et al (2021) A new twist: the combination of Sulbactam\/Avibactam enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) isolates. Antibiot (Basel) 10(5):577. https:\/\/doi.org\/10.3390\/antibiotics10050577","journal-title":"Antibiot (Basel)"},{"issue":"2","key":"4840_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/oxfordjournals.aje.a113990","volume":"121","author":"RW Haley","year":"1985","unstructured":"Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP et al (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121(2):182\u2013205. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a113990","journal-title":"Am J Epidemiol"},{"issue":"3","key":"4840_CR9","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1093\/cid\/ciac647","volume":"76","author":"SM Smoke","year":"2023","unstructured":"Smoke SM, Brophy A, Reveron S, Iovleva A, Kline EG, Marano M et al (2023) Evolution and transmission of Cefiderocol-Resistant Acinetobacter baumannii during an outbreak in the burn Intensive Care Unit. Clin Infect Dis off Publ Infect Dis Soc Am 76(3):e1261\u2013e1265. https:\/\/doi.org\/10.1093\/cid\/ciac647","journal-title":"Clin Infect Dis off Publ Infect Dis Soc Am"},{"key":"4840_CR10","doi-asserted-by":"publisher","unstructured":"Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J et al (2023) Clinical outcomes and bacterial characteristics of Carbapenem-resistant Acinetobacter Baumannii among patients from different global regions Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciad556","DOI":"10.1093\/cid\/ciad556"},{"issue":"4","key":"4840_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA et al (2022) European Society of Clinical Microbiology and Infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis 28(4):521\u2013547. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.025","journal-title":"Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"4840_CR12","doi-asserted-by":"publisher","unstructured":"Gill CM, Santini D, Takemura M, Longshaw C, Yamano Y, Echols R et al (2023 Apr) In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime\/avibactam, ampicillin\/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkad032","DOI":"10.1093\/jac\/dkad032"},{"key":"4840_CR13","doi-asserted-by":"publisher","unstructured":"Pasteran F, Cedano J, Baez M, Albornoz E, Rapoport M, Osteria J et al (2021) A New Twist: The Combination of Sulbactam\/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates. Antibiotics (Basel). May https:\/\/doi.org\/10.3390\/antibiotics10050577","DOI":"10.3390\/antibiotics10050577"},{"key":"4840_CR14","doi-asserted-by":"publisher","unstructured":"Rodriguez CH, Brune A, Nastro M, Vay C, Famiglietti A (2020 Jul) In vitro synergistic activity of the sulbactam\/avibactam combination against extensively drug-resistant Acinetobacter baumannii. J Med Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.001211","DOI":"10.1099\/jmm.0.001211"},{"key":"4840_CR15","doi-asserted-by":"publisher","unstructured":"Tiseo G, Giordano C, Leonildi A, Riccardi N, Galfo V, Limongi F et al (June 2023) Salvage therapy with sulbactam\/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization. JAC-Antimicrobial Resist 5. https:\/\/doi.org\/10.1093\/jacamr\/dlad078","DOI":"10.1093\/jacamr\/dlad078"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04840-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:04:17Z","timestamp":1721397857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04840-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04840-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that research participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Emmanuel Dudoignon, Fran\u00e7ois Camelena, Matthieu Lafaurie, Benjamin Deniau, Maite Chaussard, Lucie Guillemet, Alexandru Cupaciu, Alexandre Pharaboz, Louis Boutin, Mourad Benyamina, Manel Merim\u00e8che, Alexandre Mebazaa, Benoit Plaud, B\u00e9atrice Ber\u00e7ot and Guillaume Mellon have no conflicts of interest to declare.Marc Chaouat and Maurice Mimmoun have no conflicts of interest to declare.Francois D\u00e9pret reports consulting fees Sedana, biocartis and biomerieux and research grant ministry of health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our ethics committee approved the study (IDRCB, IRB00003835; 2013\/17NICB).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}